Scripscan:Plethico Pharmaceuticals Ltd
cmp:368
Code:532739
Story:Plethico Pharmaceuticals manufactures nutraceuticals and over-the-counter pharmaceuticals products. The company''s USbased subsidiary Natrol has a strong portfolio of brands in the healthcare and wellness segment. It caters to the US and other export markets such as CIS, Africa, Latin American countries, Gulf Co-operation Council (GCC) and South East Asian countries. In recent quarters, the company has not performed well in South East Asia, the Middle East and Eastern European markets. The company''s performance has been quite erratic since the last several quarters giving little visibility to investors on what to expect. It has a negative cash flow and debt in excess of Rs 580 crore. A substantial portion of its cash flow is utilised for capital expenditure, working capital, or repayment of debt. The consumer sentiment in the US and other parts of the world has been weak due to the ongoing uncertainty in the financial markets.This doesn''t augur well for the company.Remains a hold though at present levels.
